Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004097 | Panoply™ Human DCT Knockdown Stable Cell Line | Inquiry |
| CSC-SC004097 | Panoply™ Human DCT Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04651Z | Human DCT adenoviral particles | Inquiry |
| LV10408L | human DCT (NM_001129889) lentivirus particles | Inquiry |
| LV10409L | human DCT (NM_001922) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHW014985 | shRNA set against Danio rerio DCT (NM_131555) | Inquiry |
| SHH275333 | shRNA set against Human DCT (NM_001922.3) | Inquiry |
| SHH275337 | shRNA set against Mouse DCT (NM_010024.3) | Inquiry |
| SHW005438 | shRNA set against Chicken DCT (NM_204935) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFH004846 | Human DCT cDNA Clone(NM_001129889.1) | Inquiry |
| MiUTR3H-02335 | DCT miRNA 3'UTR clone | Inquiry |
| MiUTR3H-02336 | DCT miRNA 3'UTR clone | Inquiry |
| CDCB159867 | Human DCT ORF clone (BC028311) | Inquiry |
| CDCB166913 | Chicken DCT ORF Clone (NM_204935) | Inquiry |
| CDCB176460 | Danio rerio DCT ORF Clone (NM_131555) | Inquiry |
| CDCB185579 | Rabbit DCT ORF clone (XM_008260098.1) | Inquiry |
| CDCR054022 | Human DCT ORF clone (NM_001129889.1) | Inquiry |
| CDCR248293 | Mouse Dct ORF Clone(NM_010024.3) | Inquiry |
| CDCS407881 | Human DCT ORF Clone (BC028311) | Inquiry |
Dopachrome tautomerase (Dct) is a key enzyme involved in the kynurenine metabolism, which is a critical pathway for the degradation of tryptophan, an essential amino acid required for various physiological functions. The Dct enzyme plays a significant role in the conversion of dopachrome into 3-hydroxykynurenine, a precursor for the synthesis of various neurotransmitters and other biologically active compounds. Aberrations in the Dct gene have been implicated in various neurological and psychiatric disorders, making it an attractive target for therapeutic interventions.
The Dct enzyme is a member of the cupin superfamily, which is characterized by a conserved catalytic core domain. The enzyme is composed of two main structural domains: the N-terminal domain, which is responsible for substrate binding, and the C-terminal domain, which contains the active site and is involved in catalysis. The active site of Dct contains a cysteine residue that forms a disulfide bond with another cysteine residue in the N-terminal domain, which is essential for the enzyme's catalytic activity.
The expression of the Dct gene is regulated at multiple levels, including transcription, translation, and post-translational modification. Transcription of the Dct gene is controlled by various transcriptional factors, including Sp1 and CREB, which bind to the promoter region of the gene and regulate its expression. The expression of Dct is also influenced by epigenetic mechanisms, such as DNA methylation and histone modification. In addition, Dct expression can be regulated by alternative splicing, which leads to the production of different isoforms of the enzyme with distinct functional properties.
Aberrations in the Dct gene have been implicated in various human diseases, including neurological and psychiatric disorders, such as Parkinson's disease, Alzheimer's disease, and schizophrenia. In these diseases, the Dct enzyme is either downregulated or exhibits altered Catalytic activity. This leads to imbalances in kynurenine metabolism, which in turn can result in neurotoxicity and inflammation. Autoimmune diseases are a group of disorders characterized by the immune system attacking healthy cells and tissues, resulting in inflammation and damage. Genes like Dct can influence the immune response, making individuals more susceptible to these conditions.
Research has shown that mutations in the Dct gene can lead to defects in the function of immune cells, causing them to misfire and attack their own tissues. This contributes to the development of various autoimmune diseases, including rheumatoid arthritis, lupus, and diabetes. In addition, studies have found that individuals with a specific variation of the Dct gene are at increased risk for developing multiple sclerosis, an autoimmune disease that affects the central nervous system.
References: